The Danish pharmaceutical giant Novo Nordisk will stop allowing remote work next year, according to an internal message that Bloomberg has taken part of. From January 1, the employees will work at the office five days a week.
Earlier in the week, the Danish pharmaceutical giant announced that they are cutting their workforce by 9,000 positions. 5,000 of these affect the company's Danish operations.
